5-羟色胺3受体拮抗剂预防中度致吐性化疗引起的急性呕吐——一项随机研究。 - Suppr | 超能文献

5-HT3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy--a randomized study.

作者信息

Bonneterre J, Hecquet B

出版信息

Eur J Cancer. 1994;30A(7):1041-2. doi: 10.1016/0959-8049(94)90152-x.

DOI:10.1016/0959-8049(94)90152-x

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

5-HT3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy--a randomized study.5-羟色胺3受体拮抗剂预防中度致吐性化疗引起的急性呕吐——一项随机研究。

Eur J Cancer. 1994;30A(7):1041-2. doi: 10.1016/0959-8049(94)90152-x.

2

An overview of randomised studies comparing 5-HT3 receptor antagonists to conventional anti-emetics in the prophylaxis of acute chemotherapy-induced vomiting.比较5-羟色胺3（5-HT3）受体拮抗剂与传统止吐药预防急性化疗引起呕吐的随机研究综述。

Eur J Cancer. 1997 Jan;33(1):66-74. doi: 10.1016/s0959-8049(96)00276-6.

3

5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy.用于预防化疗引起的恶心和呕吐的5-羟色胺3（5-HT3）受体拮抗剂。其药理学与临床疗效比较

Drugs. 1998 Feb;55(2):173-89. doi: 10.2165/00003495-199855020-00002.

4

5-HT3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy--a randomised study.5-羟色胺3受体拮抗剂预防中度致吐性化疗引起的急性呕吐——一项随机研究

Eur J Cancer. 1993;29A(12):1669-72. doi: 10.1016/0959-8049(93)90101-k.

5

Prophylaxis with oral granisetron for acute emesis induced by moderately emetogenic chemotherapy.口服格拉司琼预防中度致吐性化疗引起的急性呕吐。

Semin Oncol. 1995 Aug;22(4 Suppl 10):19-23.

6

Oral serotonin type 3-receptor antagonists for prevention of chemotherapy-induced emesis.用于预防化疗引起呕吐的口服5-羟色胺3型受体拮抗剂。

Am J Health Syst Pharm. 2000 Sep 15;57(18):1685-97. doi: 10.1093/ajhp/57.18.1685.

7

Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.帕洛诺司琼：一种独特的5-羟色胺3（5-HT3）受体拮抗剂，用于预防化疗引起的急性和迟发性恶心及呕吐。

Clin Adv Hematol Oncol. 2004 May;2(5):284-9.

8

Comparative efficacy and safety of palonosetron with the first 5-HT3 receptor antagonists for the chemotherapy-induced nausea and vomiting: a meta-analysis.帕洛诺司琼与第一代 5-HT3 受体拮抗剂治疗化疗致恶心呕吐的疗效和安全性比较：一项荟萃分析。

Eur J Cancer Care (Engl). 2013 Jan;22(1):41-50. doi: 10.1111/j.1365-2354.2012.01353.x. Epub 2012 Apr 22.

9

Granisetron is equivalent to ondansetron for prophylaxis of chemotherapy-induced nausea and vomiting: results of a meta-analysis of randomized controlled trials.格拉司琼在预防化疗引起的恶心和呕吐方面与昂丹司琼等效：随机对照试验的荟萃分析结果。

Cancer. 2000 Dec 1;89(11):2301-8. doi: 10.1002/1097-0142(20001201)89:11<2301::aid-cncr19>3.0.co;2-6.

10

Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis.综述用于预防化疗引起的恶心和呕吐的现有及新型止吐药。

Hosp Pract (1995). 2015;43(4):226-34. doi: 10.1080/21548331.2015.1077095. Epub 2015 Aug 26.

引用本文的文献

1

Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy: a network meta-analysis.成人止吐药预防中度或高度致吐性化疗引起的恶心和呕吐：网状荟萃分析。

Cochrane Database Syst Rev. 2021 Nov 16;11(11):CD012775. doi: 10.1002/14651858.CD012775.pub2.

2

Comparison of antiemetic efficacy of granisetron and ondansetron in Oriental patients: a randomized crossover study.格拉司琼与昂丹司琼对东方患者的止吐疗效比较：一项随机交叉研究。

Br J Cancer. 1998 May;77(10):1683-5. doi: 10.1038/bjc.1998.277.